Share-based Payment Arrangement, Expense of VACCINEX, INC. from 30 Jun 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
VACCINEX, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2017 to 31 Dec 2024.
  • VACCINEX, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $57,000, a 45% decline year-over-year.
  • VACCINEX, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $341,000, a 28% decline year-over-year.
  • VACCINEX, INC. annual Share-based Payment Arrangement, Expense for 2024 was $341,000, a 28% decline from 2023.
  • VACCINEX, INC. annual Share-based Payment Arrangement, Expense for 2023 was $474,000, a 13% decline from 2022.
  • VACCINEX, INC. annual Share-based Payment Arrangement, Expense for 2022 was $545,000, a 0.74% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

VACCINEX, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $341,000 $57,000 -$47,000 -45% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $388,000 $76,000 -$39,000 -34% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $427,000 $112,000 -$14,000 -11% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $441,000 $96,000 -$33,000 -26% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $474,000 $104,000 -$28,000 -21% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $502,000 $115,000 -$19,000 -14% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $521,000 $126,000 -$12,000 -8.7% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $533,000 $129,000 -$12,000 -8.5% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $545,000 $132,000 -$21,000 -14% 01 Oct 2022 31 Dec 2022 10-K/A 25 Apr 2024 2023 FY
Q3 2022 $566,000 $134,000 -$22,000 -14% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $588,000 $138,000 +$10,000 +7.8% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $578,000 $141,000 +$37,000 +36% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $541,000 $153,000 +$82,000 +115% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $459,000 $156,000 +$65,000 +71% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $394,000 $128,000 -$238,000 -65% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $632,000 $104,000 -$100,000 -49% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $732,000 $71,000 -$66,000 -48% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $798,000 $91,000 -$46,000 -34% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 $844,000 $366,000 +$253,000 +224% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $591,000 $204,000 +$144,000 +240% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $447,000 $137,000 +$91,000 +198% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $356,000 $137,000 +$94,000 +219% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $262,000 $113,000 +$61,000 +117% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $201,000 $60,000 +$24,000 +67% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $177,000 $46,000 01 Oct 2018 31 Dec 2018 10-K 09 Mar 2020 2019 FY
Q3 2018 $43,000 -$146,000 -77% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $52,000 +$21,000 +68% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $36,000 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q3 2017 $189,000 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $31,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2

VACCINEX, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $341,000 -$133,000 -28% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $474,000 -$71,000 -13% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $545,000 +$4,000 +0.74% 01 Jan 2022 31 Dec 2022 10-K/A 25 Apr 2024 2023 FY
2021 $541,000 -$191,000 -26% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $732,000 +$285,000 +64% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $447,000 +$270,000 +153% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $177,000 -$142,000 -45% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2020 2019 FY
2017 $319,000 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.